Zielgerichtete Therapien in der gastrointestinalen Onkologie-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Zielgerichtete Therapien in der gastrointestinalen Onkologie

Published:2024-04 Issue:08 Volume:149 Page:440-446
ISSN:0012-0472
Container-title:DMW - Deutsche Medizinische Wochenschrift
language:de
Short-container-title:Dtsch Med Wochenschr

Author:

Lange Sebastian

Publisher

Georg Thieme Verlag KG

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-2060-2075.pdf

Reference22 articles.

1. The German Network for Personalized Medicine to enhance patient care and translational research;AL Illert;Nat Med,2023

2. Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers;P Horak;Cancer Discov,2021

3. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study;GK Abou-Alfa;Lancet Oncol,2020

4. Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma;L Goyal;N Engl J Med,2023

5. Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: The phase 3 randomized clinical ClarIDHy trial;AX Zhu;JAMA Oncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3